SCHEMBL3463391

SCHEMBL3463391

CC(C)(C)C(CNc1nc2ccccc2s1)OC(N)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.51
HPGD P15428 1/20 0.51
TSHR P16473 1/20 0.47
NPC1 O15118 7/20 0.47
RAB9A P51151 7/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
ALDH1A1 P00352 5/20 0.47
ADORA1 P30542 1/20 0.47
DYRK1A Q13627 1/20 0.47
KDM4E B2RXH2 1/20 0.46
HTT P42858 1/20 0.46
GAA P10253 2/20 0.45
CYP1A2 P05177 2/20 0.45
MAPT P10636 2/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
CYP2C19 P33261 1/20 0.44
STAT1 P42224 1/20 0.44
CSNK1D P48730 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3463393 0.74 NPC1 (0.50) MAPK1TSHRNPC1RAB9ASMN1; SMN2
SCHEMBL9098108 0.74 HDAC3 (0.55) MAPK1HPGDTSHRNPC1RAB9A
SCHEMBL9098124 0.74 HDAC3 (0.55) MAPK1HPGDTSHRNPC1RAB9A
SCHEMBL29049432 0.73 MGLL (0.61) MAPK1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL30526509 0.73 MGLL (0.61) MAPK1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL3468988 0.73 NPC1 (0.55) MAPK1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL16259088 0.72 HPGD (0.64) MAPK1HPGDNPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL8906703 0.72 HPGD (0.59) MAPK1HPGDNPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL8906707 0.72 HPGD (0.59) MAPK1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL1435770 0.71 IDO1 (0.57) MAPK1HPGDNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010010435-A2 FUSED OXAZOLE AND THIAZOLE DERIVATIVES AS TRPMS MODULATORS GLENMARK PHARMACEUTICAL S.A. (CH) 2010-01-28 WO disclosed